The National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) will conduct a site visit at Emory’s main campus on March 18th, 2014.  During the site visit, the team will review and evaluate the institution’s compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.  The site visit will primarily focus on evaluation of the University’s Institutional Biosafety Committee and the oversight program for research subject to the NIH Guidelines.